Technical Analysis for QDEL - Quidel Corporation

Grade Last Price % Change Price Change
F 49.00 1.22% 0.59
QDEL closed up 1.22 percent on Monday, March 18, 2024, on 86 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Pocket Pivot Bullish Swing Setup 1.22%
Stochastic Reached Overbought Strength 1.22%
Weak + Overbought Other 1.22%
Overbought Stochastic Strength 1.22%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 18 hours ago
Rose Above Previous Day's High about 18 hours ago
Down 2 % about 19 hours ago
Down 1% about 19 hours ago
Possible Pocket Pivot 4 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Quidel Corporation Description

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women's health, and gastrointestinal diseases. The company's products for infectious diseases include QuickVue influenza test to detect viral antigens of influenza type A and B; QuickVue Strep A tests to detect Group A Streptococcal antigen from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture; QuickVue RSV test, a rapid immunoassay for respiratory syncitial virus; and cell culture and DFA detection solutions to detect seven viral respiratory pathogens. It also offers cell-based products in various formats, including tubes, shell vials, and multi-well plates to culture and test for human viruses; ELVIS HSV system for the isolation and detection of herpes simplex virus (HSV) types 1 and 2; and a multiplex cell culture solution to isolate HSV, varicella zoster virus, and cytomegalovirus, as well as provides various analyzers and molecular assays. The company's products for women's health consist of QuickVue and RapidVue pregnancy tests to detect human chorionic gonoadotropin in serum or urine for the early detection of pregnancy; Thyretain for the diagnosis of graves, an autoimmune disease; QuickVue Chlamydia test to detect chlamydia trachomatis from endocervical swab and cytology brush specimens; and clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation, including metabolic bone markers to monitor the effectiveness of therapy in pharmaceutical and related research. In addition, it provides a fecal immunochemical test to detect the presence of blood in stool specimens; indirect fluorescent antibody products; and Helicobacter pylori tests, as well as develops diagnostic and research products in the fields of oncology, bone health, and autoimmune diseases. The company was founded in 1979 and is headquartered in San Diego, California.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Infectious Diseases Autoimmune Disease Bone Gastrointestinal Influenza Lab Testing Viruses Osteoporosis Immunoassay Herpes Search Products Gastrointestinal Disease Research Products Herpes Simplex Cell Culture Herpes Simplex Virus Body Products Clinical Pathology Diagnostic And Research Products Diagnostic Testing Solutions Helicobacter Sexually Transmitted Diseases And Infections

Is QDEL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 98.64
52 Week Low 41.75
Average Volume 1,096,635
200-Day Moving Average 71.24
50-Day Moving Average 59.13
20-Day Moving Average 46.26
10-Day Moving Average 46.26
Average True Range 2.26
RSI (14) 45.36
ADX 28.75
+DI 23.93
-DI 28.59
Chandelier Exit (Long, 3 ATRs) 42.78
Chandelier Exit (Short, 3 ATRs) 48.53
Upper Bollinger Bands 49.66
Lower Bollinger Band 42.87
Percent B (%b) 0.9
BandWidth 14.66
MACD Line -2.97
MACD Signal Line -4.29
MACD Histogram 1.3196
Fundamentals Value
Market Cap 3.27 Billion
Num Shares 66.8 Million
EPS -0.27
Price-to-Earnings (P/E) Ratio -181.48
Price-to-Sales 1.46
Price-to-Book 0.92
PEG Ratio 7.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 51.96
Resistance 3 (R3) 51.67 50.39 51.46
Resistance 2 (R2) 50.39 49.64 50.54 51.30
Resistance 1 (R1) 49.70 49.18 50.05 49.99 51.13
Pivot Point 48.42 48.42 48.60 48.57 48.42
Support 1 (S1) 47.73 47.67 48.08 48.02 46.87
Support 2 (S2) 46.45 47.21 46.60 46.70
Support 3 (S3) 45.76 46.45 46.54
Support 4 (S4) 46.05